Related references
Note: Only part of the references are listed.Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
Peter Strom et al.
LANCET ONCOLOGY (2020)
Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml
Jan Chandra Engel et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2020)
Effects of replacing PSA with Stockholm3 for diagnosis of clinically significant prostate cancer in a healthcare system - the Stavanger experience
Eirik Viste et al.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2020)
Dilemmas of medical overuse in general practice - A focus group study
Per Oystein Opdal et al.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2019)
Urological symptoms among 23,240 men in the general danish population - concerns about symptoms, their persistence and influence on primary care contacts
Majken Solvang et al.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2018)
The Diagnosis and Treatment of Prostate Cancer A Review
Mark S. Litwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies
Christopher P. Filson et al.
CANCER (2016)
Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study
Henrik Gronberg et al.
LANCET ONCOLOGY (2015)
Share Paper
